Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
Go back to Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 320.99 +0.28 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $320.71 | 52 Week High | $141.32 | |||
| Open | $321.95 | 52 Week Low | $97.79 | |||
| Day High | $323.84 | P/E | 51.36 | |||
| Day Low | $318.94 | EPS | $6.25 | |||
| Volume | 466,295 | |||||
